09/25/23 8:30 AMNasdaq : AIMD, AIMDW low floatAinos Announces Placement of Initial $3 Million Tranche of $10 Million Private PlacementProceeds to fund company's clinical trials, commercial product launch, and working capital Initial conversion price set at $1.50 per shareSAN DIEGO, CA / ACCESSWIRE / September 25, 2023 / Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcareRHEA-AIneutral
09/18/23 7:00 AMNasdaq : AIMD, AIMDW clinical triallow floatAinos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive PatientsVELDONA® positioned as a potential treatment option for over 24,000 HIV-seropositive AmericansSAN DIEGO, CA / ACCESSWIRE / September 18, 2023 / Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development ofRHEA-AIneutral
09/05/23 7:00 AMNasdaq : AIMD, AIMDW low floatAinos Commences Shipping its VELDONA Pet Cytoprotein Supplements in TaiwanFirst Batch of 300,000 Units to be Fully Delivered in OctoberAinos Has Expanded Distribution in Multiple Channels and Plans to Scale Up Capacity for Expected Strong DemandSAN DIEGO, CA / ACCESSWIRE / September 5, 2023 / Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or theRHEA-AIneutral
08/11/23 4:30 PMNasdaq : AIMD, AIMDW earningslow floatAinos Reports Second Quarter 2023 Financial ResultsStrategic Focus Continues to Pivot from COVID to Pet Health and AI-powered TestingLaunch of VELDONA® Pet Provides New Revenue Stream for Near-Term; Ainos Flora Remains on Horizon for 2024SAN DIEGO, CA / ACCESSWIRE / August 11, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or theRHEA-AIneutral
08/10/23 8:00 AMNasdaq : AIMD, AIMDW low floatAinos Celebrates First Listing Anniversary on NasdaqAinos reflects upon multiple business milestones following Nasdaq listing, as it diversifies its revenues and advances its product pipelineSAN DIEGO, CA / ACCESSWIRE / August 10, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcareRHEA-AIneutral
08/09/23 8:00 AMNasdaq : AIMD, AIMDW partnershiplow floatAinos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry AdoptionThe Collaboration Signals Era of New Innovation for AI Nose Technology for Broader Industry AdoptionWith Partnership, Ainos Makes Progress Towards Mission of Digitizing SmellSAN DIEGO, CA / ACCESSWIRE / August 9, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or theRHEA-AIneutral
06/27/23 8:30 AMNasdaq : AIMD, AIMDW low floatAinos Issues Mid-Year Business Update Letter to ShareholdersCompany ramping up marketing of VELDONA® Pet and aiming to complete clinical trials in Taiwan of its flagship AI Nose-powered POCT by the end of 2023Ainos sees VELDONA® Pet and AI Nose-powered POCT as key drivers in transforming the companySAN DIEGO, CA / ACCESSWIRE / June 27, 2023 /RHEA-AIneutral
06/20/23 8:30 AMNasdaq : AIMD, AIMDW AIlow floatAinos Provides Insights Into Its AI Nose TechnologyAinos' AI-Powered Digital Nose Technology to Transform Telehealth and Point-of-Care TestingClinical Trials of AI Nose-powered POCT to be Completed by the End of 2023, Positioning Ainos to Capitalize on US$256 Billion STI Testing MarketSAN DIEGO, CA / ACCESSWIRE / June 20, 2023 / Ainos, Inc.RHEA-AIneutral
06/14/23 9:00 AMNasdaq : AIMD, AIMDW low floatAinos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue TargetFive VELDONA® Pet products are now availableNew supplements will launch in Taiwan in July ahead of the planned international release, helping to maintain immunity for millions of petsAinos sets its sights on entering the $137 billion US pet marketSAN DIEGO, CA / ACCESSWIRE / June 14, 2023 /RHEA-AIneutral
06/07/23 9:00 AMNasdaq : AIMD, AIMDW low floatAinos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales TargetNew products support pets' emotional health and allergic responses, hit market in Taiwan following successful launch of VELDONA® PetExpanding VELDONA® Pet product line builds growth momentum toward US$20M sales target for 2024SAN DIEGO, CA / ACCESSWIRE / June 7, 2023 / Ainos, Inc.RHEA-AIneutral
